SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Clarke who wrote (18270)12/27/2003 2:06:44 AM
From: Mark Marcellus  Read Replies (1) of 78525
 
James -

Interesting question. I agree with you on the difficulty in finding stocks in this market. I also agree on ANF - Hollister especially worries me. I'm starting to think that there are problems there that management is unwilling or unable to face up to.

Re your question, here are a couple of stocks that I think will be long term (3-5 years) winners but don't expect to double in the next year:

DGX (Quest Diagnostics): The leading provider of lab services and diagnostic testing, and the leader in the industry. They are an exceptionally well run company and they have a nice razor and blade type of business. I've dealt with them in the past (both at work and as a patient) and was very favorably impressed. Strong cash flow, decent balance sheet, options are an issue. They've been hurt a little by the bad economy over the last couple of years, and if employment improves their results should benefit.

FDS (Factset Research): Provides integrated financial information services to investment banks, brokerages, etc. Based on the numbers, I think this is one of the most exciting companies out there but unfortunately, unlike Quest Diagnostics, I have had no direct dealings with them. I would be interested in hearing from anyone who has. Gross margin runs in the mid 60's, ROIC is in the mid 20's, the balance sheet is pristine, options are a problem. They are not quite as good as vintage Oracle or Microsoft - growth rates in the 20's or 30's, depending on what you're looking at - but the profitability, cash flow and balance sheet are in the same league.

The closest I can come to a "swing for the fences" is LNCR (Lincare Holdings) a provider of home respiratory therapy. This company has been putting up Coca Cola-like numbers, but they are going to be hit hard by the new Medicare pricing rules, and the stock is down over 25% as a result. I'm not so concerned about that, LNCR provides a service that saves money overall and I'm reasonably confident that things will work themselves out by 2005 when the rules take effect. My problem with LNCR is that, quite frankly, I don't completely trust management. Don't have the time to go into great detail, but a condensed version is; they have (IMO) practiced selective disclosure in the past, and they are structured as a holding company with hundreds of independent units whose results are rolled up into theirs. They are quite probably a completely legitimate operation, but I don't have the confidence to buy a lot. If they are legit, I believe they are a tremendous bargain right now.

As for what stock I'd put 25% of my portfolio in, for me that would require not only safety, but a "back up the truck" depressed price. I don't see the latter anywhere, but if I had to do it I'd consider MCD, JNJ, or BRK, all of which I consider to be very safe and reasonably priced.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext